Literature DB >> 23887163

Gastrointestinal histopathology in chronic granulomatous disease: a study of 87 patients.

Meghna Alimchandani1, Jin-Ping Lai, Phyu Phyu Aung, Sajneet Khangura, Natasha Kamal, John I Gallin, Steven M Holland, Harry L Malech, Theo Heller, Markku Miettinen, Martha M Quezado.   

Abstract

Gastrointestinal (GI) involvement in chronic granulomatous disease (CGD), a rare genetic immunodeficiency, mimics other inflammatory bowel diseases. We report GI pathology from 87 CGD patients seen at the NIH Clinical Center, with vague to severe clinical symptoms, in whom biopsies (313) had been evaluated (esophagus [23], stomach [71], small bowel [52] including duodenum [39], ileum [12], and jejunum [1], and colon [167]). Additionally reviewed was GI tissue from 15 autopsies. In our patient cohort, the mean age was 22 years (age range, 3 to 44 y; 2:1 male to female ratio). There were pathologic changes in 83/87 (95%) patients; with colon being the most commonly involved site and esophagus the least. There were microgranulomas in 53/87 (61%), pigmented macrophages in 64/87 (74%), tissue eosinophilia in 31/87 (36%), and chronic and/or acute inflammation in 57/87 (66%) patients. A subset of patients had villous shortening in the duodenum (8/39) and ileum (5/12). We identify microgranulomas in 76/167 (46%) colon, 12/52 (23%) small bowel, and 4/71 (6%) gastric biopsies; pigmented macrophages in 109/167 (65%) colon and 7/52 (13%) small bowel biopsies and 14/15 autopsies; chronic and/or acute inflammation in 97/167 (58%) colon, 13/52 (25%) small bowel, 42/71 (59%) gastric, and 5/23 (22%) esophageal biopsies; tissue eosinophilia in 43/167 (26%) colon, 7/52 (13%) small bowel, and 2/71 (3%) gastric biopsies. Only 4/87 (5%) patients had normal histology. No infectious etiology was identified in the majority of inflammatory lesions. We found that mild to severe GI pathology was common in CGD. In addition, microgranulomas, pigmented macrophages, and eosinophilia are not associated with acute (neutrophilic) inflammation.

Entities:  

Mesh:

Year:  2013        PMID: 23887163      PMCID: PMC3787986          DOI: 10.1097/PAS.0b013e318297427d

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  23 in total

Review 1.  Chronic granulomatous disease.

Authors:  Steven M Holland
Journal:  Clin Rev Allergy Immunol       Date:  2010-02       Impact factor: 8.667

Review 2.  Chronic granulomatous disease.

Authors:  Alexander J Towbin; Ian Chaves
Journal:  Pediatr Radiol       Date:  2010-02-05

3.  Colitis in chronic granulomatous disease.

Authors:  M G Schäppi; V V Smith; D Goldblatt; K J Lindley; P J Milla
Journal:  Arch Dis Child       Date:  2001-02       Impact factor: 3.791

4.  Complications of tumor necrosis factor-α blockade in chronic granulomatous disease-related colitis.

Authors:  Gulbu Uzel; Jordan S Orange; Nina Poliak; Beatriz E Marciano; Theo Heller; Steven M Holland
Journal:  Clin Infect Dis       Date:  2010-11-08       Impact factor: 9.079

5.  Chronic granulomatous disease. Report on a national registry of 368 patients.

Authors:  J A Winkelstein; M C Marino; R B Johnston; J Boyle; J Curnutte; J I Gallin; H L Malech; S M Holland; H Ochs; P Quie; R H Buckley; C B Foster; S J Chanock; H Dickler
Journal:  Medicine (Baltimore)       Date:  2000-05       Impact factor: 1.889

6.  Esophageal dysmotility in an adult with chronic granulomatous disease.

Authors:  M Golioto; J B O'Connor
Journal:  J Clin Gastroenterol       Date:  2001-10       Impact factor: 3.062

7.  The nature of colitis in chronic granulomatous disease.

Authors:  Michela G Schäppi; Nigel J Klein; Keith J Lindley; Dyanne Rampling; Virpi V Smith; David Goldblatt; Peter J Milla
Journal:  J Pediatr Gastroenterol Nutr       Date:  2003-05       Impact factor: 2.839

8.  Myeloablative transplantation using either cord blood or bone marrow leads to immune recovery, high long-term donor chimerism and excellent survival in chronic granulomatous disease.

Authors:  Priti Tewari; Paul L Martin; Adam Mendizabal; Suhag H Parikh; Kristin M Page; Timothy A Driscoll; Harry L Malech; Joanne Kurtzberg; Vinod K Prasad
Journal:  Biol Blood Marrow Transplant       Date:  2012-02-10       Impact factor: 5.742

9.  Chronic granulomatous disease: a clinical survey of 41 patients from the Iranian primary immunodeficiency registry.

Authors:  Masoud Movahedi; Asghar Aghamohammadi; Nima Rezaei; Nikrad Shahnavaz; Ali Babaei Jandaghi; Abolhasan Farhoudi; Zahra Pourpak; Mostafa Moin; Mohammad Gharagozlou; Davoud Mansouri
Journal:  Int Arch Allergy Immunol       Date:  2004-06-01       Impact factor: 2.749

10.  Chronic granulomatous disease: the European experience.

Authors:  J Merlijn van den Berg; Elsbeth van Koppen; Anders Ahlin; Bernd H Belohradsky; Ewa Bernatowska; Lucien Corbeel; Teresa Español; Alain Fischer; Magdalena Kurenko-Deptuch; Richard Mouy; Theoni Petropoulou; Joachim Roesler; Reinhard Seger; Marie-José Stasia; Niels H Valerius; Ron S Weening; Baruch Wolach; Dirk Roos; Taco W Kuijpers
Journal:  PLoS One       Date:  2009-04-21       Impact factor: 3.240

View more
  31 in total

Review 1.  Granulomas in the gastrointestinal tract: deciphering the Pandora's box.

Authors:  Ian Brown; Marian Priyanthi Kumarasinghe
Journal:  Virchows Arch       Date:  2017-08-04       Impact factor: 4.064

Review 2.  Toll-like receptor signaling in primary immune deficiencies.

Authors:  Paul J Maglione; Noa Simchoni; Charlotte Cunningham-Rundles
Journal:  Ann N Y Acad Sci       Date:  2015-04-30       Impact factor: 5.691

3.  Treatment With Anakinra, a Recombinant IL-1 Receptor Antagonist, Unlikely to Induce Lasting Remission in Patients With CGD Colitis.

Authors:  Katherine J Hahn; Nancy Ho; Lynne Yockey; Samantha Kreuzberg; Janine Daub; Amy Rump; Beatriz E Marciano; Martha Quezado; Harry L Malech; Steven M Holland; Theo Heller; Christa S Zerbe
Journal:  Am J Gastroenterol       Date:  2015-06       Impact factor: 10.864

Review 4.  Inflammatory consequences of inherited disorders affecting neutrophil function.

Authors:  Mary C Dinauer
Journal:  Blood       Date:  2019-03-21       Impact factor: 22.113

Review 5.  Gastrointestinal Manifestations and Complications of Primary Immunodeficiency Disorders.

Authors:  Shradha Agarwal; Charlotte Cunningham-Rundles
Journal:  Immunol Allergy Clin North Am       Date:  2019-02       Impact factor: 3.479

Review 6.  Inflammatory Bowel Disease in Primary Immunodeficiencies.

Authors:  Judith R Kelsen; Kathleen E Sullivan
Journal:  Curr Allergy Asthma Rep       Date:  2017-08       Impact factor: 4.806

7.  Longstanding Eosinophilia in a Case of Late Diagnosis Chronic Granulomatous Disease.

Authors:  Alan Nguyen; Kiran Patel; Jennifer Puck; Morna Dorsey
Journal:  J Clin Immunol       Date:  2016-12-13       Impact factor: 8.317

8.  Fecal Calprotectin Rise in Chronic Granulomatous Disease-Associated Colitis.

Authors:  Yumiko Nakazawa; Toshinao Kawai; Katsuhiro Arai; Eiichiro Tamura; Toru Uchiyama; Masafumi Onodera
Journal:  J Clin Immunol       Date:  2017-09-06       Impact factor: 8.317

Review 9.  [The gut: center of immunity : Rare inflammatory bowel diseases caused by immunodeficiencies].

Authors:  Carsten Posovszky; Thomas F E Barth
Journal:  Pathologe       Date:  2020-05       Impact factor: 1.011

Review 10.  Gastrointestinal Disorders Associated with Common Variable Immune Deficiency (CVID) and Chronic Granulomatous Disease (CGD).

Authors:  Mathieu Uzzan; Huaibin M Ko; Saurabh Mehandru; Charlotte Cunningham-Rundles
Journal:  Curr Gastroenterol Rep       Date:  2016-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.